BioSpace News Archive

HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointment of Meiji Seika Pharma as an exclusive distributor for its lymphoma product, HBI-8000, in Japan.

Dr. Trent Haywood, former president of the Blue Cross Blue Shield Institute and former chief medical officer of the Blue Cross Blue Shield Association (BCBSA), today announced the launch of a venture services company that will connect health care startups with payers and providers.

Eyevensys, a privately held clinical-stage biotechnology company developing non-viral gene therapies for retinal and other ophthalmic diseases, announced today that it has completed a $30 million Series B financing.

Senti Biosciences, Inc., the gene circuit company focused on outsmarting complex diseases with intelligent medicines, will participate in the 38th Annual J.P. Morgan Healthcare Conference in San Francisco.

Candel Therapeutics, a leader in developing viral immunotherapies across multiple tumor indications, announced today that it has acquired all oncolytic and other Herpes Simplex Virus (HSV) based assets from PeriphaGen, Inc., bringing its vector engineering, production expertise and next-generation HSV drug development platform in-house.

Technology optimization and clinical utility studies to enhance liquid biopsy and tissue-based genomic applications for cancer patients

Lab1636 commits to advance certain Harvard innovations toward a possible therapeutic for tactile hypersensitivity experienced in autism spectrum disorders